Streetwise Reports (09/03/2025)
Rakovina Therapeutics Inc. (RKV:TSX.V) secured fresh funding, advanced preclinical PARP and ATR programs, and leveraged exclusive AI platforms to target DNA-repair pathways. Read more for insight into its expanding role in precision oncology. Streetwise Reports (09/02/2025)
Pasofino Gold Ltd. (VEIN:TSX.V; EFRGF:OTCQB; N07:FSE) submits its annual audited financial statements for the fiscal year ending April 30, 2025. Find out the news the company got recently that moves it closer to profits at the West African project.